During the past two years, Rowpar received 10 patents in the U.S., Europe, Canada, Australia, Japan and Mexico. James Ratcliff and his father, Dr. Perry Ratcliff, teamed with other dental ...

Canker sores and cold sores are a pretty common and uncomfortable side effect of chemotherapy but a Valley company is providing some relief -- and they kind of just stumbled on the treatment. CloSYS ...

Rowpar Pharmaceuticals said that an in vitro laboratory analysis found that its CloSys ultrasensitive oral rinse reduced SARS-CoV-2 by up to 98.4% within 30 seconds. The study was conducted at an ...

A Minnesota startup developing a vascular closure device is looking to raise $2.5 million in debt and options, according to a regulatory filing. It has raised $30,000 so far. CloSys Corp. has been ...

CloSYS launched its new preflavored, alcohol-free oral healthcare rinse at the 2015 Chicago Midwinter Meeting. Offered at the same cost as the company's original unflavored rinse, the new JustRight ...